ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,378,121 | -32.8% | 110,830 | -35.9% | 0.00% | -33.3% |
| Q2 2023 | $15,434,360 | -53.6% | 172,934 | -44.3% | 0.00% | -57.1% |
| Q1 2023 | $33,281,088 | +33.8% | 310,400 | +52.4% | 0.01% | +16.7% |
| Q4 2022 | $24,875,561 | +181.2% | 203,681 | +137.8% | 0.01% | +200.0% |
| Q3 2022 | $8,846,000 | -13.9% | 85,662 | -22.5% | 0.00% | 0.0% |
| Q2 2022 | $10,272,000 | -56.9% | 110,500 | -45.6% | 0.00% | -60.0% |
| Q1 2022 | $23,823,000 | +20.6% | 202,987 | +38.3% | 0.01% | – |
| Q4 2021 | $19,746,000 | +49.1% | 146,790 | +76.7% | 0.00% | -100.0% |
| Q3 2021 | $13,241,000 | -24.1% | 83,075 | -37.4% | 0.00% | 0.0% |
| Q2 2021 | $17,446,000 | +65.6% | 132,618 | +62.3% | 0.00% | 0.0% |
| Q1 2021 | $10,532,000 | -18.3% | 81,726 | +5.8% | 0.00% | – |
| Q4 2020 | $12,888,000 | -6.7% | 77,268 | -13.7% | 0.00% | -100.0% |
| Q3 2020 | $13,813,000 | -59.6% | 89,507 | -61.3% | 0.00% | -62.5% |
| Q2 2020 | $34,163,000 | +43.9% | 230,987 | +9.5% | 0.01% | 0.0% |
| Q1 2020 | $23,748,000 | -66.1% | 210,888 | -58.2% | 0.01% | -60.0% |
| Q4 2019 | $70,111,000 | -3.5% | 503,961 | -33.2% | 0.02% | -20.0% |
| Q3 2019 | $72,637,000 | -67.8% | 754,123 | -61.5% | 0.02% | -10.7% |
| Q2 2019 | $225,843,000 | +109.3% | 1,961,306 | +114.0% | 0.03% | -36.4% |
| Q1 2019 | $107,883,000 | +256.9% | 916,600 | +90.0% | 0.04% | +266.7% |
| Q4 2018 | $30,229,000 | +86.7% | 482,500 | +111.2% | 0.01% | +140.0% |
| Q3 2018 | $16,188,000 | -20.2% | 228,442 | -25.1% | 0.01% | -28.6% |
| Q2 2018 | $20,285,000 | – | 304,945 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |